Pharma Mar, S.A.
General ticker "PHMMF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.6B (TTM average)
Pharma Mar, S.A. does not follow the US Stock Market performance with the rate: -0.3%.
Estimated limits based on current volatility of 1.5%: low 96.52$, high 99.44$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-06-26, amount 0.93$ (Y0.92%)
Short-term PHMMF quotes
Long-term PHMMF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €158.15MM | €174.85MM | €221.31MM |
| Operating Expenses | €161.98MM | €168.39MM | €181.05MM |
| Operating Income | €-3.83MM | €6.47MM | €40.26MM |
| Non-Operating Income | €0.20MM | €5.52MM | €19.37MM |
| Interest Expense | €2.42MM | €2.47MM | €1.06MM |
| R&D Expense | €99.30MM | €103.50MM | €95.16MM |
| Income(Loss) | €-3.62MM | €11.98MM | €59.63MM |
| Taxes | €-4.76MM | €0.00MM | €-15.33MM |
| Profit(Loss)* | €1.14MM | €26.12MM | €74.96MM |
| Stockholders Equity | €193.44MM | €208.36MM | €251.74MM |
| Inventory | €39.29MM | €50.89MM | €54.08MM |
| Assets | €340.52MM | €349.64MM | €394.93MM |
| Operating Cash Flow | €-13.45MM | €6.03MM | €53.11MM |
| Capital expenditure | €15.96MM | €15.51MM | €9.38MM |
| Investing Cash Flow | €-43.05MM | €1.03MM | €-60.77MM |
| Financing Cash Flow | €-32.14MM | €-5.35MM | €-36.51MM |
| Earnings Per Share** | €0.06 | €1.49 | €4.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.